Lite Strategy, Inc. (LITS)
1.09
+0.05
(+4.81%)
USD |
NASDAQ |
Sep 04, 14:29
Lite Strategy Cash and Short Term Investments (Annual) : 18.01M for June 30, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| June 30, 2025 | 18.01M |
| June 30, 2024 | 38.34M |
| June 30, 2023 | 100.69M |
| June 30, 2022 | 153.25M |
| June 30, 2021 | 153.43M |
| June 30, 2020 | 182.63M |
| June 30, 2019 | 74.49M |
| June 30, 2018 | 102.74M |
| June 30, 2017 | 53.56M |
| June 30, 2016 | 45.92M |
| June 30, 2015 | 63.78M |
| June 30, 2014 | 48.79M |
| Date | Value |
|---|---|
| June 30, 2013 | 35.57M |
| June 30, 2012 | 6.202M |
| June 30, 2011 | 3.858M |
| June 30, 2010 | 9.031M |
| June 30, 2009 | 19.07M |
| June 30, 2008 | 19.74M |
| June 30, 2007 | 16.16M |
| June 30, 2006 | 10.05M |
| June 30, 2005 | 19.24M |
| June 30, 2004 | 24.82M |
| June 30, 2003 | 29.81M |
| June 30, 2002 | 9.164M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | 71.89M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |
| Savara, Inc. | 235.70M |